According to the latest report published by Data Bridge Market Research, the Calcify Uremic Arteriolopathy Drug Market  The global calcify uremic arteriolopathy drug market was valued at USD 566.3 million in 2024 and is expected to reach USD 778.01 million by 2032, at a CAGR of 4.05% during the forecast period With the use of integrated approaches and latest technology for the...